KemPharm Receives FDA Priority Review For Drug Candidate
February 10, 2016 at 14:30 PM EST
Shares of KemPharm Inc (NASDAQ: KMPH), a clinical-stage specialty pharmaceutical company, surged higher by more than 17 percent on ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.